A carregar...
Natalizumab for induction of remission in Crohn's disease
BACKGROUND: This systematic review update summarizes the current evidence on the use of natalizumab for induction of remission in Crohn's disease (CD). OBJECTIVES: To determine the efficacy and safety of natalizumab for induction of remission in CD. SEARCH METHODS: We searched MEDLINE, Embase,...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2018
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513248/ https://ncbi.nlm.nih.gov/pubmed/30068022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006097.pub3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|